Next Generation Sequencing in Renal Cell Carcinoma: Towards Precision Medicine

Roy Elias; Akanksha Sharma; Nirmish Singla; James Brugarolas

Next Generation Sequencing in Renal Cell Carcinoma: Towards Precision Medicine

Kidney Cancer J. 2019;17(4):94-104.

Authors

Roy Elias^{1

2}, Akanksha Sharma¹, Nirmish Singla³, James Brugarolas^{1

2}

Affiliations

¹ Department of Internal Medicine, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas TX, 75390.
² Department of Kidney Cancer Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas TX, 75390.
³ Department of Urology, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas TX, 75390.

PMID: 32206160
PMCID: PMC7089604

No abstract available

Keywords: BAP1; Kidney cancer; PBRM1; genomics; immune checkpoint inhibitor; molecularly targeted therapies; next generation sequencing; renal cell carcinoma.

Grants and funding

T32 CA136515/CA/NCI NIH HHS/United States